Breaking News: MAPS’ final FDA approval study confirms that MDMA-Assisted Therapy is safe and effective
In a big step towards the legalization of MDMA-Assisted Therapy, Nature Medicine just published the results from the final study required by the FDA before the culmination of the MDMA-AT approval process.
“Introduction: MDMA-Assisted Therapy 101″ with Darek Dawda – MDMA THERAPY PODCAST #14
In this introduction to MDMA-Assisted Therapy, Dr. Darek Dawda discusses a few key concepts necessary for the understanding of this novel therapy.
“Personal Accounts of the MDMA Experience: Stories from the Psychedelic Science 2023 Denver Conference (Part 3) with Rick Doblin and many others – MDMA THERAPY PODCAST #13
In this 3-episode podcast series, we present numerous personal accounts of experiences with MDMA, both in the recreational and therapeutic context. These interviews were recorded at the historic Psychedelic Science 2023 conference in Denver, the largest gathering to date of people who work on advancing the research, access, and legalization of psychedelic-assisted therapies.
“Personal Accounts of the MDMA Experience: Stories from the Psychedelic Science 2023 Denver Conference (Part 2) with Rick Doblin and many others – MDMA THERAPY PODCAST #12
In this 3-episode podcast series, we present numerous personal accounts of experiences with MDMA, both in the recreational and therapeutic context. These interviews were recorded at the historic Psychedelic Science 2023 conference in Denver, the largest gathering to date of people who work on advancing the research, access, and legalization of psychedelic-assisted therapies.
Australia is now leading the way in access to MDMA- and Psilocybin-Assisted therapies
As of July 1st, 2023, Australia has made MDMA- and Psilocybin-Assisted Therapies available to those in need. MDMA-AT is now available for PTSD, and Psilocybin-AT is available for treatment-resistant depression.
<strong>Psychedelic Science 2023 Conference: A Portal to a Good Future</strong>
The Enhanced Therapy team just got back from the historic Psychedelic Science 2023 Conference in Denver, the coming together of over 12,000 people, all passionate about the emerging science and practice of new and promising psychedelic-assisted therapies.
“Personal Accounts of the MDMA Experience: Stories from the Psychedelic Science 2023 Denver Conference (Part 1) with Rick Doblin and many others – MDMA THERAPY PODCAST #11
In this 3-episode podcast series, we present numerous personal accounts of experiences with MDMA, both in the recreational and therapeutic context. These interviews were recorded at the historic Psychedelic Science 2023 conference in Denver, the largest gathering to date of people who work on advancing the research, access, and legalization of psychedelic-assisted therapies.
A psychedelic trip that is becoming a reality
MDMA-Assisted Therapy is bound to become the first psychedelic-assisted therapy approved for mental health treatment.
MDMA-Assisted Therapy — One step closer to FDA approval
MDMA-Assisted Therapy (MAT) is one step closer to becoming medically available. After an epic 36-year long journey, the MAPS Public Benefit Corporation has completed data collection for the Phase 3 study of MAT for PTSD. As of November 22, 2022, the data set has been locked and is now ready for statistical analysis.
“Manual for Psychedelic Guides” with Mark Haden – MDMA THERAPY PODCAST #10
Working within the Harm Reduction approach, Mark Haden (Director of Research @ PsyGen, Professor of Public Health @ UBC, and Former Executive Director of MAPS Canada) discusses his book “Manual for Psychedelic Guides.” Mark’s insights are also applicable to MDMA-Assisted Therapy and other Psychedelic-Assisted Therapies.
